Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0O7DN
|
||||
Former ID |
DIB002216
|
||||
Drug Name |
CEP-427
|
||||
Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Terminated | [546139] | ||
Company |
Cephalon Inc
|
||||
Target and Pathway | |||||
Target(s) | Tumor necrosis factor receptor superfamily member 16 | Target Info | Modulator | [543520] | |
Pathway Interaction Database | p75(NTR)-mediated signaling | ||||
Neurotrophic factor-mediated Trk receptor signaling | |||||
Reactome | Axonal growth inhibition (RHOA activation) | ||||
NRAGE signals death through JNK | |||||
p75NTR negatively regulates cell cycle via SC1 | |||||
Regulated proteolysis of p75NTR | |||||
NADE modulates death signalling | |||||
NRIF signals cell death from the nucleus | |||||
p75NTR recruits signalling complexes | |||||
NF-kB is activated and signals survival | |||||
Axonal growth stimulation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.